📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 19:49
510 analysed today
510
Today
133,399
All-time analysed
40,108
Positive
6,279
Negative
79,197
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
22 announcements match the current filters (relevance ≥ 5).
Sadhana Nitrochem Allots 6.75 Cr Shares at Rs 2.06; Approves Q1 FY27 Results
Sadhana Nitrochem has approved the allotment of 6.75 crore equity shares on a preferential basis at a price of Rs 2.06 per share. This action raises approximately Rs 13.91 crore, representing about 9.1% of the company's current market capitalization of Rs 152 crore. The board also approved the unaudited financial results for the quarter ended June 30, 2026. This capital infusion comes at a time when the company is facing significant financial stress, with a TTM loss of Rs 87 crore and debt of Rs 113 crore.
Confidence: HIGH
What changedThe company has increased its equity base by 6.75 crore shares through a preferential allotment, resulting in a capital infusion of ~Rs 13.91 crore.
Why it mattersThe fundraise provides a small liquidity buffer for a company struggling with heavy losses and high debt, though the amount is small compared to the Rs 113 crore debt burden. The issuance at Rs 2.06 represents a discount to the current market price of Rs 3.0, leading to equity dilution.
Shares Allotted: 6,75,00,000Issue Price: Rs 2.06Fundraise Value: Rs 13.91 CrFundraise vs Market Cap: ~9.1%New Paid-up Capital: Rs 303.22 Cr
📅 Short termThe market may react to the equity dilution and the fact that the issue price (Rs 2.06) is significantly lower than the current market price (Rs 3.0).
📈 Long termThe company's long-term viability depends on restarting its 6,000 TPA PAP plant and overcoming Chinese dumping pressures; this small fundraise does not fundamentally alter the structural challenges.
⚠ Risk flags
- Equity dilution
- Persistent net losses (Rs -87 Cr TTM)
- High debt-to-revenue ratio
- Issue price below current market price
Key Highlights
Allotment of 6,75,00,000 fully paid-up equity shares at an issue price of Rs 2.06 per share
Total fundraise value of approximately Rs 13.91 crore
Paid-up equity share capital increased from Rs 296.47 crore to Rs 303.22 crore
Approval of unaudited standalone and consolidated financial results for Q1 FY27
Issue price of Rs 2.06 includes a premium of Rs 1.06 per share
👀 What to Watch
Investors should closely examine the detailed Q1 FY27 financial statements to check for any recovery in operating margins, which were -107.4% in the previous trailing twelve months. Monitor the utilization of the Rs 13.91 crore proceeds to see if it is directed toward debt reduction or working capital for the non-operational PAP plant.
6.75 Cr Shares: Sadhana Nitrochem Receives In-Principle Approval for Preferential Issue
Sadhana Nitrochem has received in-principle approval from both BSE and NSE for a preferential issue of 6,75,00,000 equity shares of Re. 1/- each. This fundraise comes at a critical time as the company reported a TTM net loss of Rs 87 crore and negative operating margins of -107.4%. The equity infusion is likely intended to bolster liquidity or address the company's Rs 113 crore debt, given that its 6,000 TPA PAP plant remained non-operational in H2FY25 due to market conditions.
Confidence: HIGH
What changedThe company has cleared the regulatory hurdle of obtaining stock exchange approval to proceed with a significant equity issuance.
Why it mattersThis fundraise is essential for the company's survival and potential turnaround, as it provides necessary capital to manage debt and potentially restart idle manufacturing capacities amid intense Chinese competition.
Shares to be issued: 6,75,00,000Face Value: Re. 1/-TTM Net Profit: Rs -87 CrTotal Debt: Rs 113 CrMarket Cap: Rs 134 Cr
📅 Short termThe approval is a positive sentiment driver as it validates the company's ability to raise capital despite recent heavy losses. Expect focus on the upcoming allotment date.
📈 Long termThe long-term impact depends on whether the capital is used to pivot toward high-margin products like ODB2 or to sustain the PAP segment against Chinese dumping. Significant dilution is a structural concern for minority shareholders.
⚠ Risk flags
- Equity dilution
- Operational losses (TTM PAT Rs -87 Cr)
- High debt-to-revenue ratio
- Intense competition from Chinese imports
Key Highlights
Received in-principle approval for the issuance of 6,75,00,000 equity shares of face value Re. 1/- each.
Approval granted by NSE on July 27, 2026, and subsequently by BSE.
Company is currently loss-making with a TTM PAT of Rs -87 crore against TTM revenue of Rs 50 crore.
Total debt stands at Rs 113 crore as of the latest financial context, making capital infusion vital.
Promoter holding recently increased to 60.91% as of March 2026 from 29.97% in December 2025.
👀 What to Watch
Investors should monitor the announcement of the final issue price and the identity of the allottees to understand the extent of equity dilution and promoter commitment. The key execution milestone will be the restart of the 6,000 TPA PAP plant using these funds.
Sadhana Nitrochem Reports Q1 FY26 Net Loss of ₹1.7 Cr; Divests Subsidiary and CFO Resigns
Sadhana Nitrochem Limited (SADHNANIQ) reported a net loss of ₹1.70 crore for the quarter ended June 30, 2025, compared to a profit of ₹3.99 crore in the preceding quarter. Revenue from operations declined to ₹28.10 crore from ₹40.07 crore in Q4 FY25. The company also announced the divestment of its entire stake in subsidiary Calchem Industries and the resignation of its CFO, Rakesh R. Kothari. To mitigate financial strain, executive directors waived 55% of their remuneration, totaling ₹69 lakhs.
Key Highlights
Revenue from operations fell to ₹2,810 lakhs in Q1 FY26 from ₹3,084 lakhs in the same quarter last year.
Reported a net loss of ₹170 lakhs against a marginal profit of ₹4 lakhs in Q1 FY25.
Divested 100% stake in wholly-owned subsidiary Calchem Industries (India) Limited on May 28, 2025.
CFO Rakesh R. Kothari resigned effective August 14, 2025, replaced by new leadership in Finance and Operations.
Executive Directors waived ₹69 lakhs in remuneration to support the company's financial position.
👀 What to Watch
Investors should exercise caution as the company has swung into a loss and is undergoing significant management and structural changes. Monitor the performance of the new management team and the impact of the subsidiary divestment on future cash flows.
Sadhana Nitrochem to Issue 6.75 Crore Equity Shares at ₹2.06 via Preferential Allotment
Sadhana Nitrochem Limited has finalized the pricing for its preferential allotment of 6,75,00,000 equity shares. Following consultation with the National Stock Exchange, the floor price was determined to be ₹2.05 based on the 90-day volume-weighted average price (VWAP). The company has confirmed it will proceed with an allotment price of ₹2.06 per share, which is slightly above the regulatory floor. This move marks a significant equity issuance to raise capital for the company's operations or expansion.
Key Highlights
Issue and allotment of 6,75,00,000 equity shares with a face value of Re. 1 each.
Allotment price fixed at ₹2.06 per share, staying above the calculated floor price of ₹2.05.
Floor price based on 90-day VWAP was ₹2.05, while the 10-day VWAP was ₹2.03.
The issuance is being conducted on a preferential basis under SEBI ICDR Regulations.
The pricing discovery was finalized in consultation with the National Stock Exchange of India.
👀 What to Watch
Investors should note the capital infusion which could support growth, but also be aware of the equity dilution resulting from the 6.75 crore new shares. Monitor the company's subsequent filings regarding the specific use of these proceeds.
Sadhana Nitrochem Bags Rs 108 Cr Long-Term Export Order from Japanese MNC
Sadhana Nitrochem Limited has entered into a significant long-term supply contract with a Japanese multinational for the export of speciality chemicals. The contract has a firm committed value of approximately Rs. 108 crores to be executed over a two-year period. This new order has propelled the company's total confirmed order book to over Rs. 200 crores. This development provides strong revenue visibility and validates the company's standing in the international speciality chemicals market.
Key Highlights
Secured a long-term export contract worth approximately Rs. 108 crores.
Contract duration is set for two years with a Japanese multinational customer.
Total confirmed order book now stands at over Rs. 200 crores.
The deal focuses on the international supply of speciality chemical products.
👀 What to Watch
Investors should monitor the company's execution capabilities and the resulting impact on quarterly revenue growth. The significant increase in the order book provides a positive outlook for the medium term.
Sadhana Nitrochem Reports Zero Deviation in Utilization of Rs 263.53 Cr Rights Issue Proceeds
Sadhana Nitrochem Limited has confirmed that there is no deviation or variation in the utilization of the Rs 263.53 Crores raised through its Rights Issue in March 2026. As of the quarter ended March 31, 2026, the company has already utilized Rs 251.95 Crores towards its stated objectives. Significant portions of the funds were deployed for Inter-Corporate Deposits (Rs 129.09 Cr) and Promoters Loans (Rs 80.76 Cr). The monitoring agency, Acuite Ratings and Research Limited, and the company's Audit Committee have reviewed and verified these disbursements.
Key Highlights
Successfully raised Rs 263.53 Crores through a Rights Issue completed on March 12, 2026.
Utilized Rs 251.95 Crores (approximately 95.6% of proceeds) by March 31, 2026.
Allocated Rs 129.09 Crores for Inter-Corporate Deposits and Rs 80.76 Crores for Promoters Loans.
Confirmed zero deviation from the original objects of the issue as per SEBI Regulation 32.
Monitoring agency Acuite Ratings and Research Limited oversaw the fund utilization process.
👀 What to Watch
Investors should take confidence in the management's transparency and rapid deployment of capital as per the stated prospectus. No further action is required as the company is in full compliance with regulatory fund-use disclosures.
Sadhana Nitrochem FY26 Results: No Dividend Declared, ₹251.95 Cr Rights Issue Proceeds Utilized
Sadhana Nitrochem approved its audited financial results for FY26, receiving an unmodified opinion from statutory auditors. The board opted not to recommend a dividend for the year, focusing instead on operational execution and capital deployment. A key update was the confirmation that ₹251.95 crores from the recent Rights Issue have been fully utilized for their intended purposes as of March 31, 2026. The company also strengthened its governance by appointing new Internal and Cost Auditors and adding the CFO to the Risk Management Committee.
Key Highlights
Audited FY26 financial results approved with an unmodified audit opinion from M/s. Jayesh Dadia & Associates LLP.
Board recommended no dividend for the financial year 2025-26.
Confirmed utilization of ₹251.95 crores in Rights Issue proceeds for specified objects till March 31, 2026.
Appointed M/s. Chandrashekhar Iyer & Co as Internal Auditor and M/s. Vinay Mulay & Co as Cost Auditor for FY27.
CFO Vimal R. Jain inducted into the Risk Management Committee to enhance oversight.
👀 What to Watch
Investors should analyze the full financial report to evaluate the ROI generated from the ₹251.95 crore capital deployment. The decision to skip dividends suggests a priority on reinvestment or liquidity preservation which warrants a closer look at the cash flow statement.
Sadhana Nitrochem FY26 Results: No Dividend Declared; Rs 251.95 Cr Rights Issue Fully Utilized
Sadhana Nitrochem's board approved the audited financial results for FY26 with an unmodified audit opinion, indicating no major accounting discrepancies. The company has decided not to recommend a dividend for the financial year 2025-26, which may suggest a focus on capital preservation or reinvestment. Crucially, the board confirmed that the entire Rs. 251.95 Crores raised via the Rights Issue has been utilized for its intended purposes as of March 31, 2026. Additionally, new Internal and Cost Auditors have been appointed for the 2026-27 fiscal year to maintain regulatory compliance.
Key Highlights
Audited standalone and consolidated financial results for FY26 approved with an unmodified audit opinion.
No dividend recommended by the Board of Directors for the financial year 2025-26.
Confirmed utilization of Rs. 251.95 Crores from the Rights Issue proceeds for specified objects.
Appointment of M/s. Chandrashekhar Iyer & Co as Internal Auditor and M/s. Vinay Mulay & Co as Cost Auditor for FY 2026-27.
CFO & President of Operations and Finance, Mr. Vimal R. Jain, added to the Risk Management Committee.
👀 What to Watch
Investors should examine the full financial statements to evaluate the company's profitability and growth trajectory, especially given the decision to skip dividends. The full utilization of Rights Issue funds suggests that planned projects or debt repayments associated with the issue are now complete.
Sadhana Nitrochem Shareholders Approve Preferential Allotment and Capital Increase at EGM
Sadhana Nitrochem Limited (SADHNANIQ) held an Extraordinary General Meeting on May 22, 2026, where shareholders approved several critical resolutions. Key approvals include the issuance of equity shares via preferential allotment to private investors and an increase in the company's authorized share capital. Shareholders also cleared the appointment of Mrs. Sindhu Suneer Kotian as an Independent Director and the continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond the age of 70. All resolutions were passed with significant majorities, indicating strong shareholder support for the management's growth and capital-raising plans.
Key Highlights
Preferential allotment of equity shares to private investors approved with 99.78% votes in favour.
Increase in Authorised Share Capital and consequent MOA alteration passed with 99.73% majority.
Continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond age 70 approved with 88.69% support.
Total voting participation represented approximately 62.63% of the total outstanding shares for most resolutions.
Appointment of Mrs. Sindhu Suneer Kotian as Non-Executive Independent Director secured 99.73% approval.
👀 What to Watch
Investors should monitor the specific pricing and identity of the private investors in the preferential allotment to assess potential equity dilution. The approval for capital expansion suggests the company is positioning itself for significant future growth or debt restructuring.
Sadhana Nitrochem Shareholders Approve Preferential Allotment and Capital Increase
Sadhana Nitrochem Limited (SADHNANIQ) has received overwhelming shareholder approval for a preferential allotment of equity shares to private investors, with 99.78% of votes in favor. The company also secured approval to increase its authorized share capital and alter its Memorandum of Association to facilitate this growth. Additionally, shareholders approved the continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond the age of 70 and the appointment of a new Independent Director. These results indicate strong shareholder support for the company's capital-raising plans and management stability.
Key Highlights
Preferential allotment of equity shares to private investors approved with 99.78% majority.
Increase in Authorized Share Capital and MoA alteration passed with 99.73% support.
Continuation of Mr. Asit Dhankumar Javeri as Executive Director (beyond age 70) approved with 88.69% valid votes.
Appointment of Mrs. Sindhu Suneer Kotian as Non-Executive Independent Director secured 99.73% approval.
Total of 1.85 billion votes polled for the capital increase and preferential allotment resolutions.
👀 What to Watch
Investors should monitor the specific pricing and the list of investors for the preferential allotment, as this capital infusion is intended for expansion but will result in equity dilution.
Sadhana Nitrochem Issues Corrigendum for EGM; Preferential Allotment Price Fixed at ₹2.06
Sadhana Nitrochem Limited has issued a corrigendum to its EGM notice regarding a preferential allotment of equity shares. The floor price for the issue has been determined at ₹2.0272 per share based on SEBI ICDR regulations, while the actual allotment price is set at ₹2.06 per share. The company clarified that Mr. Niraj Bajaj's pre-preferential holding is 14.75 crore shares (4.98%), which will increase to 20 crore shares (6.60%) post-allotment. Another investor, Poorvi Milan Chitalia, is set to invest ₹3.09 crore for a 0.49% stake.
Key Highlights
Preferential allotment price fixed at ₹2.06 per equity share, higher than the SEBI floor price of ₹2.0272
Mr. Niraj Bajaj to increase stake from 4.98% (14.75 crore shares) to 6.60% (20 crore shares) with an investment of ₹10.815 crore
Poorvi Milan Chitalia to invest ₹3.09 crore for a post-allotment stake of 0.49%
The 10-day Volume Weighted Average Price (VWAP) was calculated at ₹2.0272, while the 90-day VWAP was ₹1.7894
Extra-Ordinary General Meeting (EGM) to be held on May 22, 2026, via video conferencing
👀 What to Watch
Investors should monitor the outcome of the EGM on May 22, as the successful completion of this preferential allotment will provide fresh capital and increase the stake of a key investor.
Sadhana Nitrochem to Raise ₹13.9 Cr via Preferential Issue; EGM Scheduled for May 22
Sadhana Nitrochem Limited has scheduled an Extraordinary General Meeting (EGM) on May 22, 2026, to seek approval for a preferential allotment of 6.75 crore equity shares. The company aims to raise approximately ₹13.905 crore by issuing shares at ₹2.06 each to private investors Niraj Bajaj and Poorvi Milan Chitalia. Other key agenda items include increasing the authorized share capital to ₹305 crore and the continuation of Mr. Asit Javeri as Executive Director beyond the age of 70. This capital infusion and leadership continuity are central to the company's immediate strategic plans.
Key Highlights
Preferential allotment of 6,75,00,000 equity shares at ₹2.06 per share to raise ₹13.905 crore.
Lead investor Niraj Bajaj to be allotted 5,25,00,000 shares, representing the bulk of the issue.
Proposal to increase Authorized Share Capital from ₹300 crore to ₹305 crore.
EGM to be held via Video Conferencing on May 22, 2026, with a cut-off date of May 15 for voting eligibility.
Special resolution for the continuation of Mr. Asit Dhankumar Javeri as Executive Director beyond age 70.
👀 What to Watch
Investors should note the equity dilution resulting from the 6.75 crore new shares but view the entry of a strategic investor like Niraj Bajaj as a positive endorsement. Monitor the company's subsequent disclosures regarding the specific utilization of these funds for growth or debt reduction.
Sadhana Nitrochem to Raise ₹13.91 Crore via Preferential Allotment; Increases Authorized Capital
Sadhana Nitrochem's board has approved a preferential allotment of 6.75 crore equity shares at ₹2.06 each to raise approximately ₹13.91 crore for working capital needs. A key highlight is the increased participation of investor Niraj Bajaj, whose stake will rise from 4.98% to 6.60% post-allotment. The company is also increasing its authorized share capital from ₹300 crore to ₹305 crore to accommodate this issuance. An Extraordinary General Meeting (EGM) is scheduled for May 22, 2026, to obtain shareholder approval for these corporate actions.
Key Highlights
Approved preferential allotment of 6,75,00,000 equity shares at an issue price of ₹2.06 per share.
Total fundraise of approximately ₹13.91 crore intended for working capital support.
Investor Niraj Bajaj to increase his shareholding from 4.98% to 6.60% post-issue.
Authorized share capital increased from ₹300 crore to ₹305 crore.
Extraordinary General Meeting (EGM) convened for May 22, 2026, to finalize approvals.
👀 What to Watch
Investors should view the stake increase by a prominent investor as a sign of confidence, though they should monitor the company's ability to improve margins with the additional working capital. Keep an eye on the EGM results on May 22 for final confirmation of the allotment terms.
Sadhana Nitrochem Receives Trading Approval for 263.52 Crore Rights Issue Shares
Sadhana Nitrochem Limited has secured final trading approval from both BSE and NSE for 2,63,52,83,328 equity shares issued via its recent Rights Issue. These shares, with a face value of Re. 1 each, were issued at par and will be admitted for trading effective March 17, 2026. This marks the completion of a massive equity expansion, which will significantly increase the company's total share capital and liquidity in the market.
Key Highlights
Trading approval received for 2,63,52,83,328 equity shares of Re. 1/- each.
New shares were issued at par (Re. 1) on a rights basis.
Trading of the new shares is scheduled to commence on March 17, 2026.
Approval letters received from BSE (LOD/RIGHTS/SV/69/2025-2026) and NSE (NSE/LIST/2026/54054).
👀 What to Watch
Investors should be cautious as the massive influx of over 263 crore new shares may lead to significant equity dilution and short-term price volatility. Monitor how the company utilizes the raised capital to drive future earnings growth to offset the dilution.
Sadhana Nitrochem Allots 263.5 Crore Equity Shares via Rights Issue at ₹1 Each
Sadhana Nitrochem Limited has successfully completed the allotment of 263,52,83,328 equity shares following its Rights Issue. The shares were issued at a price of ₹1 per equity share, significantly expanding the company's equity base. As a result, the paid-up equity share capital has increased from ₹32.94 crore to ₹296.47 crore. While 5,128 shares are kept in abeyance pending clearances, the new shares will rank pari-passu with existing equity.
Key Highlights
Allotment of 263,52,83,328 fully paid-up equity shares at an issue price of ₹1 per share
Paid-up equity share capital increased from ₹32,94,11,057 to ₹2,96,46,94,385
5,128 Rights Equity Shares kept in abeyance pending regulatory or other clearances
New shares rank pari-passu in all respects with existing fully paid-up equity shares
👀 What to Watch
Investors should be aware of the significant equity dilution as the share capital has increased nearly nine-fold. Monitor the company's utilization of these funds and the subsequent impact on Earnings Per Share (EPS).
Sadhana Nitrochem Sets February 19, 2026, as Record Date for Rights Issue
Sadhana Nitrochem Limited has officially designated February 19, 2026, as the record date for its upcoming Rights Issue. This date is crucial as it determines which shareholders are eligible to receive Rights Entitlements (REs) in their demat accounts. The company is proceeding with this capital raising activity in compliance with SEBI Listing and Disclosure requirements. Investors must hold the shares on or before this date to participate in the offering.
Key Highlights
The official record date for the Rights Issue is fixed for February 19, 2026.
The purpose is to identify shareholders eligible for Rights Entitlements under the proposed issue.
The announcement follows compliance with Regulation 42 of SEBI LODR and Regulation 68 of SEBI ICDR.
The ISIN for the Rights Entitlement is identified as INE888C20024.
👀 What to Watch
Existing shareholders should check the rights price and ratio once announced to decide on exercising their rights. Those wishing to participate must ensure they hold the shares by the record date to receive entitlements.
Sadhana Nitrochem Approves ₹263.53 Crore Rights Issue with 8:1 Ratio
Sadhana Nitrochem Limited has finalized the terms for a significant rights issue totaling ₹263.53 crore. The company will issue 263.53 crore new equity shares at a price of Re. 1 per share, which is at par with the face value. Existing shareholders are entitled to 8 new shares for every 1 share held as of the record date. The record date for this corporate action is set for February 19, 2026.
Key Highlights
Total rights issue size fixed at ₹26,352.92 lakhs (approximately ₹263.53 crore)
Rights entitlement ratio set at 8 fully paid-up equity shares for every 1 share held
Issue price determined at Re. 1 per share, representing zero premium over face value
Record date for eligibility established as February 19, 2026
Total number of fresh rights shares to be issued is 263,52,92,056
👀 What to Watch
Investors should be aware of the massive equity dilution resulting from the 8:1 ratio and decide whether to subscribe to maintain their ownership percentage. Monitor the stock price closely as it will likely adjust significantly on the ex-rights date.
Sadhana Nitrochem Q3 Results: Revenue Drops 81% YoY to ₹5.66 Cr; Posts ₹25.4 Cr Net Loss
Sadhana Nitrochem reported a dismal set of numbers for Q3 FY26, with revenue from operations crashing 81% YoY to ₹5.66 crore. The company swung to a net loss of ₹25.40 crore from a profit of ₹0.64 crore in the previous year's corresponding quarter. Management highlighted technical constraints, liquidity challenges, and US tariff-related trade uncertainties as the primary drivers for this downturn. For the nine-month period, the company has accumulated a net loss of ₹53.48 crore, significantly impacting its financial health.
Key Highlights
Quarterly revenue from operations plummeted to ₹566.26 lakhs from ₹2,975 lakhs YoY.
Net loss for Q3 FY26 widened to ₹2,540 lakhs compared to a profit of ₹64 lakhs in Q3 FY25.
Finance costs rose to ₹688 lakhs from ₹464 lakhs YoY, reflecting increased debt servicing pressure.
Total comprehensive loss for the nine-month period ended Dec 2025 stood at ₹5,361 lakhs.
Management cited US tariff uncertainties and technical production constraints as primary reasons for the decline.
👀 What to Watch
The sharp decline in revenue and mounting losses suggest significant operational and external headwinds. Investors should remain cautious and monitor the promised Q4 recovery closely before making new commitments.
Sadhana Nitrochem Reports Q3 Net Loss of ₹25.4 Cr; Revenue Drops 81% YoY
Sadhana Nitrochem Limited reported a standalone net loss of ₹25.40 crore for the quarter ended December 31, 2025, a sharp decline from a profit of ₹0.64 crore in the same period last year. Revenue from operations fell significantly by 81% YoY to ₹5.66 crore, although it showed a sequential recovery from the previous quarter's low of ₹0.26 crore. The company cited technical production constraints, liquidity challenges, and global trade uncertainties in US and European markets as primary reasons for the poor performance. Management expects an operational recovery in Q4 FY26 as these issues have reportedly been addressed.
Key Highlights
Standalone revenue from operations plummeted 81% YoY to ₹5.66 crore from ₹29.75 crore.
Reported a net loss of ₹25.40 crore in Q3 FY26 against a profit of ₹0.64 crore in Q3 FY25.
9-month standalone net loss reached ₹53.48 crore compared to a profit of ₹1.23 crore in the prior year period.
Finance costs increased to ₹6.88 crore from ₹4.64 crore YoY, reflecting higher interest burden.
Management attributed losses to technical constraints and US tariff-related uncertainties affecting export schedules.
👀 What to Watch
Investors should exercise caution as the company has transitioned to significant losses and a severely reduced revenue base. The stock remains a 'Watch' to see if the management's guidance of a Q4 recovery and resolution of technical/liquidity issues actually translates into improved financials.
Sadhana Nitrochem: Postal Ballot for Director Appointment
Sadhana Nitrochem Limited is seeking shareholder approval via postal ballot for the appointment of Mr. Tej Mayur Contractor (DIN: 00454197) as a Non-Executive Independent Director. The appointment is for a term of 5 years, commencing from October 18, 2025, up to October 17, 2030. The e-voting period will commence on December 17, 2025, at 9:00 A.M. (IST) and conclude on January 15, 2026, at 5:00 P.M. (IST). The results will be declared on or before January 17, 2026.
Key Highlights
Appointment of Mr. Tej Mayur Contractor (DIN: 00454197) as Non-Executive Independent Director.
Director term: 5 years, from October 18, 2025 to October 17, 2030.
E-voting starts December 17, 2025, at 9:00 A.M. (IST).
E-voting ends January 15, 2026, at 5:00 P.M. (IST).
👀 What to Watch
Shareholders should review the postal ballot notice and cast their votes electronically between December 17, 2025, and January 15, 2026. Ensure your email address is registered with the company/depositories to receive the notice and e-voting details.
